Ask about this productRelated genes to: SLC1A5 Blocking Peptide
- Gene:
- SLC1A5 NIH gene
- Name:
- solute carrier family 1 member 5
- Previous symbol:
- RDRC, M7V1
- Synonyms:
- AAAT, ASCT2
- Chromosome:
- 19q13.32
- Locus Type:
- gene with protein product
- Date approved:
- 1994-09-27
- Date modifiied:
- 2016-02-17
Related products to: SLC1A5 Blocking Peptide
Related articles to: SLC1A5 Blocking Peptide
- - Source: PubMed
Publication date: 2026/04/30
Chen HongyuLi Chengchen - Diabetic retinopathy (DR) represents a key microvascular disorder resulting from prolonged diabetes mellitus. Hyperglycemia, a common driver of diabetes-related vision loss, can pathologically activate lipogenesis (DNL); however, the underlying mechanisms remain incompletely understood. This work sought to profile signature genes correlated with DNL and DR, and offer novel insights into the disease's underlying pathogenesis. - Source: PubMed
Publication date: 2026/04/07
Jin ZhenghongDong YichenXue RongFan XialianWan Guangming - - Source: PubMed
Publication date: 2026/04/20
Yao XinqiWu JieSong YuShen Hao - Head and Neck Squamous Cell Carcinoma (HNSCC) is associated with high mortality due to tumor proliferation and metastasis. Altered function of metabolic transporters such as glutamine transporter SLC1A5 in tumor cells and their microenvironment plays a crucial role in proliferation and metastasis. The aim of this study was to assess the expression of SLC1A5 in HNSCC and evaluate its prognostic significance using computational analysis. - Source: PubMed
Publication date: 2026/04/03
Kaarunya SSinduja PalatiYuwanati MonalMullainathan Senthilmurugan - Lung neuroendocrine tumors (LNETs) span well-differentiated typical/atypical carcinoids (TC/AC) to poorly differentiated large-cell neuroendocrine carcinoma (LCNEC). Robust biomarkers for grading and prognostication are lacking. We hypothesized that differential metabolic pathways activation, reflected by protein expression, holds prognostic relevance. We conducted a monocentric translational study on resected LNETs to characterize biomarkers involved in glycolysis, fatty acid, and amino acid pathways across different grades of LNETs. Secondary endpoints included assessing clinical outcomes and correlating biomarker expression with patient prognosis. - Source: PubMed
Publication date: 2026/04/10
Pasello GiuliaPigato GiuliaMulargiu CristianaFerrarini FedericaPezzuto FedericaSchiavon MarcoFerro AlessandraScattolin DanielaMaso Alessandro DalFrega StefanoBonanno LauraCalabrese FiorellaDell'Amore AndreaGuarneri ValentinaIndraccolo Stefano